KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $68,000 | -9.3% | 20,000 | 0.0% | 0.01% | -13.3% |
| Q2 2018 | $75,000 | -8.5% | 20,000 | 0.0% | 0.02% | -6.2% |
| Q1 2018 | $82,000 | -11.8% | 20,000 | 0.0% | 0.02% | -15.8% |
| Q4 2017 | $93,000 | -34.5% | 20,000 | 0.0% | 0.02% | -34.5% |
| Q3 2017 | $142,000 | -2.1% | 20,000 | 0.0% | 0.03% | -3.3% |
| Q2 2017 | $145,000 | +17.9% | 20,000 | 0.0% | 0.03% | +20.0% |
| Q1 2017 | $123,000 | +5.1% | 20,000 | 0.0% | 0.02% | -7.4% |
| Q4 2016 | $117,000 | +10.4% | 20,000 | 0.0% | 0.03% | +12.5% |
| Q3 2016 | $106,000 | -19.7% | 20,000 | 0.0% | 0.02% | -27.3% |
| Q2 2016 | $132,000 | -29.4% | 20,000 | -50.0% | 0.03% | -29.8% |
| Q1 2016 | $187,000 | +85.1% | 40,000 | +100.0% | 0.05% | +80.8% |
| Q4 2015 | $101,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |